switching to tirzepatide Early Dose Escalation of after from Semaglutide in Type 2 Diabetes Mellitus I switched from semaglutide to

Importantly, in most CVOTs the combined use of the two drug classes was not a prespecified endpoint

While both medications have similar mechanisms of action and can contribute to weight loss, there are some key differences to consider: Weight loss effectiveness: Semaglutide (Ozempic) has been found to lead to more significant weight loss compared to liraglutide (Saxenda)

10.1016/j.cmet.2015.02.005 Cell Metab

GLP-1s tied to lower risk for 10 types of cancer compared with insulin in type 2 diabetes People with type 2 diabetes who use a GLP-1 receptor agonist have a lower risk for 10 types of obesity-associated cancer compared with those who use insulin, according to data published in JAMA Network Open